Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Blue Jet Healthcare Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹363.31Fairly Valued by 3.51%vs CMP ₹351.00

P/E (20.7) × ROE (30.2%) × BV (₹72.40) × DY (0.34%)

₹249.48Overvalued by 28.92%vs CMP ₹351.00
MoS: -40.7% (Negative)Confidence: 58/100 (Moderate)Models: 2 Under, 7 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹400.0122%Under (+14%)
Graham NumberEarnings₹166.1216%Over (-52.7%)
Earnings PowerEarnings₹88.5411%Over (-74.8%)
DCFCash Flow₹281.5813%Over (-19.8%)
Net Asset ValueAssets₹72.407%Over (-79.4%)
EV/EBITDAEnterprise₹227.069%Over (-35.3%)
Earnings YieldEarnings₹169.407%Over (-51.7%)
ROCE CapitalReturns₹510.449%Under (+45.4%)
Revenue MultipleRevenue₹59.375%Over (-83.1%)
Consensus (9 models)₹249.48100%Overvalued
Key Drivers: Wide model spread (₹59–₹510) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 10.1%

*Investments are subject to market risks

Analyst Summary

Blue Jet Healthcare Ltd operates in the Pharmaceuticals segment, NSE: BLUEJET | BSE: 544009, current market price is ₹351.00, market cap is 6,089 Cr.. At a glance, stock P/E is 20.7, ROE is 30.2 %, ROCE is 39.8 %, book value is 72.4, dividend yield is 0.34 %. The latest intrinsic value estimate is ₹249.48, around 28.9% below the current price, so expectations may already be running ahead of this modelled fair value. On operating trend, latest reported sales are about ₹1,030 Cr versus the prior period change of 44.7%, while latest net profit is about ₹305 Cr with a prior-period change of 86.0%. The 52-week range shown on this page is 1,028/325, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative AnalysisBlue Jet Healthcare Ltd is a Public Limited Listed company incorporated on 07/12/1968 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) i…

This summary is generated from the stock page data available for Blue Jet Healthcare Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.

Investment Snapshot

68
Blue Jet Healthcare Ltd scores 68/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health87/100 · Strong
ROCE 39.8% ExcellentROE 30.2% ExcellentD/E 0.30 ModerateInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money45/100 · Moderate
FII holding down -1.14% (6mo) SellingDII holding up 3.32% MF buyingPromoter holding at 79.8% Stable
Earnings Quality40/100 · Moderate
OPM stable around 35% SteadyWorking capital: 157 days Capital intensive
Quarterly Momentum68/100 · Strong
Revenue (4Q): +21% YoY AcceleratingProfit (4Q): +25% YoY PositiveOPM: 24.0% (down 15.0% YoY) Margin pressure
Industry Rank90/100 · Strong
P/E 20.7 vs industry 53.8 Cheaper than peersROCE 39.8% vs industry 16.4% Above peersROE 30.2% vs industry 15.2% Above peers3Y sales CAGR: 15% Moderate

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 4:16 am

Market Cap 6,089 Cr.
Current Price 351
Intrinsic Value₹249.48
High / Low 1,028/325
Stock P/E20.7
Book Value 72.4
Dividend Yield0.34 %
ROCE39.8 %
ROE30.2 %
Face Value 2.00
PEG Ratio2.05

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Blue Jet Healthcare Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Blue Jet Healthcare Ltd 6,089 Cr. 351 1,028/32520.7 72.40.34 %39.8 %30.2 % 2.00
Aarti Pharmalabs Ltd 5,757 Cr. 635 972/55726.7 2260.79 %17.4 %14.5 % 5.00
Entero Healthcare Solutions Ltd 5,424 Cr. 1,247 1,511/94446.6 4060.00 %8.71 %5.63 % 10.0
FDC Ltd 5,345 Cr. 328 528/31323.0 1491.52 %15.9 %11.8 % 1.00
Shilpa Medicare Ltd 7,328 Cr. 375 502/26041.4 1250.13 %7.82 %4.21 % 1.00
Industry Average19,815.15 Cr1,053.8453.84201.200.39%16.35%15.16%6.10

All Competitor Stocks of Blue Jet Healthcare Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 169217180181167184163208318340355165192
Expenses 117147121119112131119139194200234111146
Operating Profit 52705963555344691241401215547
OPM % 31%32%33%35%33%29%27%33%39%41%34%33%24%
Other Income 6658-39912131282413
Interest 0000000000150
Depreciation 7666883555666
Profit before tax 51705864445449771321471236954
Tax % 27%27%24%26%27%27%24%24%25%25%26%24%25%
Net Profit 385144483240385899110915240
EPS in Rs 2.162.922.542.761.852.292.183.365.716.355.263.012.32

Last Updated: March 3, 2026, 11:42 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 27, 2026, 1:50 am

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 5384996837217121,0301,053
Expenses 325292434502481652690
Operating Profit 214207249219231378363
OPM % 40%41%36%30%32%37%34%
Other Income 691924184658
Interest 7531006
Depreciation 18202225281822
Profit before tax 194190243217220406393
Tax % 25%26%25%26%26%25%
Net Profit 145142182160164305294
EPS in Rs 24,118.331,428.7710.479.239.4417.5916.94
Dividend Payout % 0%0%0%0%11%7%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-2.07%28.17%-12.09%2.50%85.98%
Change in YoY Net Profit Growth (%)0.00%30.24%-40.26%14.59%83.48%

Blue Jet Healthcare Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2020-2021 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:%
5 Years:14%
3 Years:15%
TTM:76%
Compounded Profit Growth
10 Years:%
5 Years:16%
3 Years:19%
TTM:118%
Stock Price CAGR
10 Years:%
5 Years:%
3 Years:%
1 Year:48%
Return on Equity
10 Years:%
5 Years:31%
3 Years:27%
Last Year:31%

Last Updated: September 5, 2025, 2:45 pm

Balance Sheet

Last Updated: December 4, 2025, 2:33 am

MonthMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 0.60103535353535
Reserves 1983304876478111,0981,221
Borrowings 745219532121
Other Liabilities 92142173176211263251
Total Liabilities 3645347138621,0591,4181,527
Fixed Assets 107139156151172300303
CWIP 2333014789159
Investments 263794189250187210
Other Assets 229355460491489841855
Total Assets 3645347138621,0591,4181,527

Reserves and Borrowings Chart

Cash Flow

MonthMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 12213714614224146
Cash from Investing Activity + -45-61-76-147-264-35
Cash from Financing Activity + -72-21-56-4-2-19
Net Cash Flow 55514-10-24-8
Free Cash Flow 106851258368-34
CFO/OP 80%66%70%92%109%36%

Free Cash Flow

MonthMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow140.00155.00230.00214.00228.00357.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 8010512112191124
Inventory Days 120201133137151209
Days Payable 9010172583570
Cash Conversion Cycle 110204183199206262
Working Capital Days 5510510312092157
ROCE %58%53%35%30%40%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 86.00%86.00%86.00%86.00%86.00%86.00%86.00%79.81%79.81%
FIIs 2.93%2.01%2.02%2.18%1.10%2.28%1.97%1.83%1.14%
DIIs 3.70%3.04%2.14%1.75%2.02%1.33%0.95%3.63%4.65%
Public 7.37%8.97%9.83%10.06%10.87%10.38%11.08%14.74%14.41%
No. of Shareholders 55,58948,62542,88241,93343,00354,58170,77280,11780,187

Shareholding Pattern Chart

No. of Shareholders

Blue Jet Healthcare Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund 2,043,158 1.22 82.811,849,0572026-03-23 16:21:3210.5%
UTI Small Cap Fund 506,107 0.45 20.51N/AN/AN/A
JM Midcap Fund 63,000 0.23 2.5599,7492026-03-11 10:19:40-36.84%
JM Flexicap Fund 3,109 0 0.13104,2382026-03-12 00:08:09-97.02%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 21Mar 20
FaceValue 100.00100.00
Basic EPS (Rs.) 1396.271462.59
Diluted EPS (Rs.) 1396.271462.59
Cash EPS (Rs.) 1568.3027166.33
Book Value[Excl.RevalReserv]/Share (Rs.) 3428.3432238.33
Book Value[Incl.RevalReserv]/Share (Rs.) 3428.3432238.33
Revenue From Operations / Share (Rs.) 5033.6189699.16
PBDIT / Share (Rs.) 2168.4336589.16
PBIT / Share (Rs.) 1970.0533582.66
PBT / Share (Rs.) 1862.9632354.50
Net Profit / Share (Rs.) 1369.9224159.83
NP After MI And SOA / Share (Rs.) 1396.4324141.33
PBDIT Margin (%) 43.0740.79
PBIT Margin (%) 39.1337.43
PBT Margin (%) 37.0136.07
Net Profit Margin (%) 27.2126.93
NP After MI And SOA Margin (%) 27.7426.91
Return on Networth / Equity (%) 40.7375.40
Return on Capital Employeed (%) 52.3283.21
Return On Assets (%) 25.9438.58
Long Term Debt / Equity (X) 0.080.19
Total Debt / Equity (X) 0.100.30
Asset Turnover Ratio (%) 1.100.00
Current Ratio (X) 2.431.89
Quick Ratio (X) 1.691.37
Inventory Turnover Ratio (X) 2.300.00
Interest Coverage Ratio (X) 40.4929.79
Interest Coverage Ratio (Post Tax) (X) 27.5820.67

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Blue Jet Healthcare Ltd is a Public Limited Listed company incorporated on 07/12/1968 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L99999MH1968PLC014154 and registration number is 014154. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company's Total Operating Revenue is Rs. 1029.99 Cr. and Equity Capital is Rs. 34.69 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Pharmaceuticals701, 702, 7th Floor, Navi Mumbai Maharashtra 400705Contact not found
Management
NamePosition Held
Mr. Akshay Bansarilal AroraExecutive Chairman
Mr. Shiven Akshay AroraManaging Director
Mr. Naresh Suryakant ShahExecutive Director
Mr. Popat B KedarExecutive Director
Ms. Divya Sameer MomayaIndependent Director
Mr. Girish Paman VanvariIndependent Director
Ms. Preeti Gautam MehtaIndependent Director
Ms. Priyanka YadavIndependent Director

FAQ

What is the intrinsic value of Blue Jet Healthcare Ltd and is it undervalued?

As of 25 April 2026, Blue Jet Healthcare Ltd's intrinsic value is ₹249.48, which is 28.92% lower than the current market price of ₹351.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (30.2 %), book value (₹72.4), dividend yield (0.34 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Blue Jet Healthcare Ltd?

Blue Jet Healthcare Ltd is trading at ₹351.00 as of 25 April 2026, with a FY2026-2027 high of ₹1,028 and low of ₹325. The stock is currently near its 52-week low. Market cap stands at ₹6,089 Cr..

How does Blue Jet Healthcare Ltd's P/E ratio compare to its industry?

Blue Jet Healthcare Ltd has a P/E ratio of 20.7, which is below the industry average of 53.84. Trading at a steep discount to peers could signal a value opportunity or reflect concerns about the company's fundamentals.

Is Blue Jet Healthcare Ltd financially healthy?

Key indicators for Blue Jet Healthcare Ltd: ROCE of 39.8 % indicates efficient capital utilization; ROE of 30.2 % shows strong shareholder returns. Dividend yield is 0.34 %.

Is Blue Jet Healthcare Ltd profitable and how is the profit trend?

Blue Jet Healthcare Ltd reported a net profit of ₹305 Cr in Mar 2025 on revenue of ₹1,030 Cr. Compared to ₹182 Cr in Mar 2022, the net profit shows an improving trend.

Does Blue Jet Healthcare Ltd pay dividends?

Blue Jet Healthcare Ltd has a dividend yield of 0.34 % at the current price of ₹351.00. The company pays dividends, though the yield is modest.

Last Updated: April 2, 2026, 4:16 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 544009 | NSE: BLUEJET
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Blue Jet Healthcare Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports